CNIC versus Covid-19

  • Against COVID-19, the CNIC develops clinical trials in positive patients. Together with the Dr. Salvador Allende Teaching Surgical Hospital, the application of Ozonotherapy for the reduction of viral load in already infected patients is being studied.
  • Another response of the CNIC to COVID-19 has been the development of OLEOSOL, a hydroalcoholic emulsion with proven effectiveness in hand disinfection, with the OLEOZON as a fundamental component that ensures high germicidal power and durability in the hands of the disinfectant and protective effect.
  • While researching, developing and producing our conventional lines of products of natural origin, the IASB welcomes the launch of a new line of 30g ozonated oil soaps.
  • In coordinated efforts with MINSAP, our researchers are working on the evaluation of a protocol for the application of ozone therapy in COVID-positive people19, based on the properties of Ozone to improve oxygen metabolism and improve systemic inflammatory response.
  • The use of the Dermatological Soap has Oleozon as active ingredient, guarantees a safe disinfection of our hands and skin in general, taking into account that there is no microbial resistance or adverse effects for its frequent use.

Pages